BriaCell TherapeuticsBCTX 
$0.82-4.84%24h
-4.84%24h
Global rank31965
Market cap$12.78M
Change 7d36.40%
YTD Performance-86.13%
SP500 benchmarkUnderperform
P/E-0.63
P/S0
Revenue$0
Earnings-$20.30M
Dividend yield-
BriaCell Therapeutics (BCTX) Net Assets
BCTX Net Assets in 2023: $-5.05M
As of 27 Aug 2024, BriaCell Therapeutics net assets is $-5.05M, an decrease of -136.57% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the BriaCell Therapeutics overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
BriaCell Therapeutics Net Assets History from 2019 to 2024
-
Value:-
BCTX Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $-5.05M | -136.57% |
| 2022 | $13.81M | -62.67% |
| 2021 | $37.01M | -1128.70% |
| 2020 | $-3.60M | 2.97% |
| 2019 | $-3.49M | - |
View the Top Net Assets Companies
